Author:
Perdomo Carolina M.,Martin-Calvo Nerea,Ezponda Ana,Mendoza Francisco J.,Bastarrika Gorka,Garcia-Fernandez Nuria,Herrero José I.,Colina Inmaculada,Escalada Javier,Frühbeck Gema
Funder
Spanish Institute of Health ISCIII
Publisher
Springer Science and Business Media LLC
Reference79 articles.
1. Mantovani A, Lombardi R, Cattazzo F, Zusi C, Cappelli D, Dalbeni A. MAFLD and CKD: an updated narrative review. Int J Mol Sci. 2022;23:1–11.
2. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102(5S):S1–127.
3. Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021;398(10302):786–802.
4. Lezaic V. Albuminuria as a biomarker of the renal disease. Biomarkers Kidney Dis. 2015;81:1–18.
5. Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3:514–25.